The Use of New Omics Techniques for Natural Products to Improve Drug Efficiency and Mechanism

References

1. KoriemK. Proteomic approach in human health and disease: Preventive and cure studies.Asian Pac. J. Trop. Biomed.20188422623610.4103/2221‑1691.231285
   [Google Scholar]
2. KoriemK.M.M. Protective effect of natural products and hormones in colon cancer using metabolome: A physiological overview.Asian Pac. J. Trop. Biomed.201771095796610.1016/j.apjtb.2017.09.002
   [Google Scholar]
3. KoriemK.M.M. Lipidome is lipids regulator in gastrointestinal tract and it is a life collar in COVID-19: A review.World J. Gastroenterol.2021271375410.3748/wjg.v27.i1.37 33505149
   [Google Scholar]
4. ChuY. ShanX. ChenT. JiangM. WangY. WangQ. SalahubD.R. XiongY. WeiD.Q. DTI-MLCD: Predicting drug-target interactions using multi-label learning with community detection method.Brief. Bioinform.2021223bbaa20510.1093/bib/bbaa205 32964234
   [Google Scholar]
5. LinS. WangY. ZhangL. ChuY. LiuY. FangY. JiangM. WangQ. ZhaoB. XiongY. WeiD.Q. MDF-SA-DDI: Predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism.Brief. Bioinform.2022231bbab42110.1093/bib/bbab421 34671814
   [Google Scholar]
6. WörheideM.A. KrumsiekJ. KastenmüllerG. ArnoldM. Multi-omics integration in biomedical research – A metabolomics-centric review.Anal. Chim. Acta2021114114416210.1016/j.aca.2020.10.038 33248648
   [Google Scholar]
7. HeathJ.R. RibasA. MischelP.S. Single-cell analysis tools for drug discovery and development.Nat. Rev. Drug Discov.201615320421610.1038/nrd.2015.16 26669673
   [Google Scholar]
8. FoxJ.T. MyungK. Cell-based high-throughput screens for the discovery of chemotherapeutic agents.Oncotarget20123558158510.18632/oncotarget.513 22653910
   [Google Scholar]
9. AminS. RattnerJ. KeramatiM.R. FarshidfarF. McNamaraM.G. KnoxJ.J. KopciukK. VogelH.J. BatheO.F. A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome.PLoS One2019144e021394210.1371/journal.pone.0213942 30939138
   [Google Scholar]
10. XuT. ZhaoH. WangM. ChowA. FangM. Metabolomics and in silico docking-directed discovery of small-molecule enzyme targets.Anal. Chem.20219363072308110.1021/acs.analchem.0c03684 33541075
    [Google Scholar]
11. ZampieriM. ZimmermannM. ClaassenM. SauerU. Nontargeted metabolomics reveals the multilevel response to antibiotic perturbations.Cell Rep.20171961214122810.1016/j.celrep.2017.04.002 28494870
    [Google Scholar]
12. NajmF.J. MadhavanM. ZarembaA. ShickE. KarlR.T. FactorD.C. MillerT.E. NevinZ.S. KantorC. SargentA. QuickK.L. SchlatzerD.M. TangH. PapoianR. BrimacombeK.R. ShenM. BoxerM.B. JadhavA. RobinsonA.P. PodojilJ.R. MillerS.D. MillerR.H. TesarP.J. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.Nature2015522755521622010.1038/nature14335 25896324
    [Google Scholar]
13. PushpakomS. IorioF. EyersP.A. EscottK.J. HopperS. WellsA. DoigA. GuilliamsT. LatimerJ. McNameeC. NorrisA. SanseauP. CavallaD. PirmohamedM. Drug repurposing: Progress, challenges and recommendations.Nat. Rev. Drug Discov.2019181415810.1038/nrd.2018.168 30310233
    [Google Scholar]
14. WagesP.A. KimH.Y.H. KoradeZ. PorterN.A. Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol.J. Lipid Res.201859101916192610.1194/jlr.M086991 30087204
    [Google Scholar]
15. GeeraertsS.L. KampenK.R. RinaldiG. GuptaP. PlanqueM. LourosN. HeylenE. De CremerK. De BruckerK. VereeckeS. VerbelenB. VermeerschP. SchymkowitzJ. RousseauF. CassimanD. FendtS.M. VoetA. CammueB.P.A. ThevissenK. De KeersmaeckerK. Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis-addicted breast tumor growth.Cancer Ther.2021201506310.1158/1535‑7163.MCT‑20‑0480 33203732
    [Google Scholar]